Integra Lifesciences's market cap is currently $1.70B. The company's EPS TTM is $-0.089; its P/E ratio is ―; Integra Lifesciences is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $0.85. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.54B	$ 1.56B	$ 1.54B	$ 1.37B	$ 1.52B
Gross Profit	$ 888.39M	$ 970.31M	$ 944.64M	$ 851.03M	$ 952.88M
Operating Income	$ 111.53M	$ 238.92M	$ 197.23M	$ 151.37M	$ 178.98M
EBITDA	$ 274.01M	$ 391.10M	$ 366.33M	$ 267.93M	$ 231.03M
Net Income	$ 67.74M	$ 180.55M	$ 169.07M	$ 133.89M	$ 50.20M
Balance Sheet
Cash & Short-Term Investments	$ 309.10M	$ 456.66M	$ 513.45M	$ 470.17M	$ 198.91M
Total Assets	$ 3.78B	$ 3.89B	$ 3.78B	$ 3.62B	$ 3.30B
Total Debt	$ 1.68B	$ 1.62B	$ 1.65B	$ 1.66B	$ 1.46B
Net Debt	$ 1.41B	$ 1.16B	$ 1.14B	$ 1.19B	$ 1.26B
Total Liabilities	$ 2.19B	$ 2.09B	$ 2.10B	$ 2.10B	$ 1.89B
Stockholders' Equity	$ 1.59B	$ 1.80B	$ 1.68B	$ 1.51B	$ 1.42B
Cash Flow
Free Cash Flow	$ 73.09M	$ 217.38M	$ 264.35M	$ 139.94M	$ 239.15M
Operating Cash Flow	$ 139.96M	$ 264.47M	$ 312.43M	$ 203.83M	$ 373.68M
Investing Cash Flow	$ -94.18M	$ -58.58M	$ -161.44M	$ -68.07M	$ -304.73M
Financing Cash Flow	$ -229.93M	$ -251.95M	$ -98.23M	$ 121.63M	$ 64.46M

Currency in USD

Integra Lifesciences Earnings and Revenue History

Income Statement >

Integra Lifesciences Debt to Assets

Balance Sheet >

Integra Lifesciences Cash Flow

Cash Flow >

Integra Lifesciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing